Translations:GLP-1 receptor agonist/14/en

Adverse effects

The most common adverse effects of GLP-1 agonists are gastrointestinal. These adverse effects limit the maximum tolerated dose and require gradual dose escalation. Nausea is directly related to the serum concentration of the GLP-1 agonist and is more commonly reported, in up to three-quarters, of people using short-acting GLP-1 agonists but fewer of those using long-acting agonists. Reactions at the injection site are also common, especially with shorter acting drugs.